Clinical Trial Update: Safety and Tolerability of IRL757 in Participants With Parkinson's Disease and Apathy [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update notes that IRL757 is being studied for safety and tolerability in people with Parkinson's disease who have apathy, across Phase 1 and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• IRL757

Snippet

Sponsor: Integrative Research Laboratories AB | Conditions: PARKINSON DISEASE (Disorder), Apathy | Phase 1, Phase 2 | Status: RECRUITING